- Home
- ALNY vs UAL Comparison
ALNY vs UAL Comparison
Compare ALNY & UAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALNY
- UAL
- Stock Information
- Founded
- ALNY 2002
- UAL 1934
- Country
- ALNY United States
- UAL United States
- Employees
- ALNY N/A
- UAL N/A
- Industry
- ALNY Biotechnology: Pharmaceutical Preparations
- UAL Air Freight/Delivery Services
- Sector
- ALNY Health Care
- UAL Consumer Discretionary
- Exchange
- ALNY Nasdaq
- UAL Nasdaq
- Market Cap
- ALNY 33.1B
- UAL 31.6B
- IPO Year
- ALNY 2004
- UAL N/A
- Fundamental
- Price
- ALNY $245.44
- UAL $97.40
- Analyst Decision
- ALNY Buy
- UAL Strong Buy
- Analyst Count
- ALNY 23
- UAL 16
- Target Price
- ALNY $298.59
- UAL $95.70
- AVG Volume (30 Days)
- ALNY 671.5K
- UAL 5.1M
- Earning Date
- ALNY 02-13-2025
- UAL 01-21-2025
- Dividend Yield
- ALNY N/A
- UAL N/A
- EPS Growth
- ALNY N/A
- UAL N/A
- EPS
- ALNY N/A
- UAL 8.30
- Revenue
- ALNY $2,094,795,000.00
- UAL $55,994,000,000.00
- Revenue This Year
- ALNY $25.14
- UAL $6.56
- Revenue Next Year
- ALNY $17.35
- UAL $7.00
- P/E Ratio
- ALNY N/A
- UAL $11.73
- Revenue Growth
- ALNY 21.54
- UAL 6.67
- 52 Week Low
- ALNY $141.98
- UAL $37.02
- 52 Week High
- ALNY $304.39
- UAL $105.09
- Technical
- Relative Strength Index (RSI)
- ALNY 43.56
- UAL 58.50
- Support Level
- ALNY $233.41
- UAL $90.17
- Resistance Level
- ALNY $249.58
- UAL $97.48
- Average True Range (ATR)
- ALNY 7.63
- UAL 3.65
- MACD
- ALNY -0.21
- UAL -1.11
- Stochastic Oscillator
- ALNY 48.68
- UAL 48.46
About ALNY Alnylam Pharmaceuticals Inc.
Alnylam Pharmaceuticals is a leader in the study of RNA interference (RNAi) therapeutics. RNAi is a naturally occurring biological pathway within cells for sequence-specific silencing and regulation of gene expression. Alnylam has five drugs on the market: Onpattro and Amvuttra for hATTR amyloidosis, Givlaari for acute hepatic porphyria, Oxlumo for primary hyperoxaluria type 1, and Leqvio for hypercholesterolemia. It also has several clinical programs across various therapeutic areas: genetic medicines; cardio-metabolic diseases; hepatic infectious diseases, and CNS/ocular diseases. Upfront fees from research partnerships have boosted Alnylam's cash levels, and the company stands to see additional milestones and royalties from drugs commercialized under collaboration partnerships.
About UAL United Airlines Holdings Inc.
United Airlines is a major us network carrier with hubs in San Francisco, Chicago, Houston, Denver, Los Angeles, New York/Newark, and Washington, D.C. United operates a hub-and-spoke system that is more focused on international and long-haul travel than its large us peers.